SCHEMBL260275

SCHEMBL260275

CC(C)(Br)C(=O)NCCCC=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.38
ALDH1A1 P00352 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CA3 P07451 2/20 0.37
CA5A P35218 2/20 0.37
CA5B Q9Y2D0 2/20 0.37
CA12 O43570 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
CA6 P23280 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
EPHX1 P07099 1/20 0.35
CNR1 P21554 1/20 0.35
DRD4 P21917 3/20 0.34
DRD2 P14416 2/20 0.34
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL260600 0.84 POLB (0.47) POLBALDH1A1SMN1; SMN2CA3CA5A
SCHEMBL649228 0.83 POLB (0.39) POLBALDH1A1SMN1; SMN2CA3CA5A
SCHEMBL6446695 0.78 POLB (0.46) POLBALDH1A1SMN1; SMN2CA3CA5A
SCHEMBL22351756 0.78 EPHX1 (0.52) POLBALDH1A1SMN1; SMN2EPHX1TSHR
SCHEMBL14052421 0.78 PTGS1 (0.47) POLBALDH1A1SMN1; SMN2CA3CA5A
SCHEMBL7292154 0.77 MEN1 (0.45) POLBALDH1A1SMN1; SMN2CA3CA5A
SCHEMBL6975512 0.76 ALDH1A1 (0.68) POLBALDH1A1SMN1; SMN2CA3CA5A
SCHEMBL280234 0.76 TDP1 (0.52) POLBALDH1A1SMN1; SMN2CA3CA5A
SCHEMBL16268506 0.75 POLB (0.38) POLBALDH1A1SMN1; SMN2CA3CA5A
SCHEMBL14930059 0.74 POLB (0.39) POLBALDH1A1SMN1; SMN2CA3CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8445612-B2 Conjugation reactions BIOCOMPATIBLES UK LIMITED (GB) 2013-05-21 US disclosed
US-8445612-B2 Conjugation reactions BIOCOMPATIBLES UK LIMITED (GB) 2013-05-21 US disclosed
US-20120016082-A1 CONJUGATION REACTIONS BIOCOMPATIBLES UK LIMITED (GB) 2012-01-19 US disclosed
US-8053520-B2 Conjugation reactions BIOCOMPATIBLES UK LIMITED (GB) 2011-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120016082-A1 CONJUGATION REACTIONS PHPT1, GNE, MGMT POLB 284/4885ALDH1A1 1053/4885SMN1; SMN2 3385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.